Cancer Res Treat.  2020 Jan;52(1):207-217. 10.4143/crt.2019.053.

Inequalities in Awareness and Attitude towards HPV and Its Vaccine between Local and Migrant Residents Who Participated in Cervical Cancer Screening in Shenzhen, China

• Lin W
• Wang Y
• Liu Z
• Chen B
• Yuan S
• Wu B
• Gong L

• KMID: 2501214
• DOI: http://doi.org/10.4143/crt.2019.053

Abstract

Purpose
A cross-sectional survey was conducted to evaluate the differences on awareness and attitude towards human papillomavirus (HPV) and its vaccine between local and migrant residents who participated in cervical cancer screening in Shenzhen, China.
Materials and Methods
A total of 9,855 females sampled from healthcare institutions in 20 street blocks through the Cervical Cancer Prevention Network were surveyed in this study by a self-administered questionnaire. Multivariate logistic regression was conducted to explore the role of the hukou and resident status in the willingness to receive HPV vaccination.
Results
Local residents had a relatively higher awareness of HPV (62.0% vs. 35.6% vs. 29.9%, p < 0.001) and its vaccine (35.3% vs. 15.4% vs. 14.8%, p < 0.001), as well as a higher willingness to receive HPV vaccination (68.5% vs. 62.5% vs. 56.2%, p < 0.001) than non-permanent residents and floating population. Except for age, education level, marital status, monthly income, having daughter(s), and heard of HPV and its vaccine, the hukou and resident status significantly associated with the willingness to receive HPV vaccination (local residents vs. floating population: odds ratio, 1.216; 95% confidence interval, 1.057 to 1.398). None significant difference on the associated factors was found between local residents and internal migrants (p for interactions > 0.05).
Conclusion
Inequalities in awareness and attitude towards HPV and its vaccine existed between local and migrant residents in Shenzhen. The hukou and resident status did impact on the willingness to receive HPV vaccination, therefore, it is critical to implement effective health education campaigns on HPV and its vaccine among internal migrants.

Keyword

Human papillomavirus; Vaccines; Awareness; Attitude; Internal migrants

Reference

References

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424.

2. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007; 370:890–907.

3. de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141:664–670.

4. World Health Organization. Comprehensive cervical cancer control: a guide to essential practice. 2nd ed. Geneva: World Health Organization;2014.

5. Lim JN, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care (Engl). 2017; 26:e12444.

6. Fisher WA, Laniado H, Shoval H, Hakim M, Bornstein J. Barriers to human papillomavirus vaccine acceptability in Israel. Vaccine. 2013; 31 Suppl 8:I53–7.

7. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66:115–32.

8. Wang B, He M, Chao A, Engelgau MM, Saraiya M, Wang L, et al. Cervical cancer screening among adult women in China, 2010. Oncologist. 2015; 20:627–34.

9. Liu T, Li S, Ratcliffe J, Chen G. Assessing knowledge and attitudes towards cervical cancer screening among rural women in eastern China. Int J Environ Res Public Health. 2017; 14:E967.

10. Bambra C, Gibson M, Sowden A, Wright K, Whitehead M, Petticrew M. Tackling the wider social determinants of health and health inequalities: evidence from systematic reviews. J Epidemiol Community Health. 2010; 64:284–91.

11. Chen J. Internal migration and health: re-examining the healthy migrant phenomenon in China. Soc Sci Med. 2011; 72:1294–301.

12. Goodkind D, West LA. China's floating population: definitions, data and recent findings. Urban Stud. 2002; 39:2237–50.

13. Li H, Chung RY, Wei X, Mou J, Wong SY, Wong MC, et al. Comparison of perceived quality amongst migrant and local patients using primary health care delivered by community health centres in Shenzhen, China. BMC Fam Pract. 2014; 15:76.

14. Yuan B, Qian X, Thomsen S. Disadvantaged populations in maternal health in China who and why? Glob Health Action. 2013; 6:19542.

15. Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012; 30:3546–56.

16. Zhao FH, Tiggelaar SM, Hu SY, Zhao N, Hong Y, Niyazi M, et al. A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev. 2012; 13:2369–78.

17. Li J, Li LK, Ma JF, Wei LH, Niyazi M, Li CQ, et al. Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine. 2009; 27:1210–5.

18. Zhang SK, Pan XF, Wang SM, Yang CX, Gao XH, Wang ZZ, et al. Perceptions and acceptability of HPV vaccination among parents of young adolescents: a multicenter national survey in China. Vaccine. 2013; 31:3244–9.

19. Chen L, Song Y, Ruan G, Zhang Q, Lin F, Zhang J, et al. Knowledge and attitudes regarding HPV and vaccination among Chinese women aged 20 to 35 years in Fujian Province: a cross-sectional study. Cancer Control. 2018; 25:107327481–8775356.

20. Gong X, Luo X, Ling L. Prevalence and associated factors of secondhand smoke exposure among internal Chinese migrant women of reproductive age: evidence from China’s Labor-Force Dynamic Survey. Int J Environ Res Public Health. 2016; 13:371.

21. He J, He L. Knowledge of HPV and acceptability of HPV vaccine among women in western China: a cross-sectional survey. BMC Womens Health. 2018; 18:130.

22. Marlow LA, Zimet GD, McCaffery KJ, Ostini R, Waller J. Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison. Vaccine. 2013; 31:763–9.

23. Zhang Y, Wang Y, Liu L, Fan Y, Liu Z, Wang Y, et al. Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies. BMC Public Health. 2016; 16:216.

24. Derose KP, Escarce JJ, Lurie N. Immigrants and health care: sources of vulnerability. Health Aff (Millwood). 2007; 26:1258–68.

25. Weiyuan C. China’s new health plan targets vulnerable. Bull World Health Organ. 2010; 88:5–6.

26. Gu H, You H, Ning W, Zhou H, Wang J, Lu Y, et al. Internal migration and maternal health service utilisation in Jiangsu, China. Trop Med Int Health. 2017; 22:124–132.

27. Nan X, Zhao X, Briones R. Parental cancer beliefs and trust in health information from medical authorities as predictors of HPV vaccine acceptability. J Health Commun. 2014; 19:100–14.

28. Oh JK, Jeong BY, Yun EH, Lim MK. Awareness of and attitudes toward human papillomavirus vaccination among adults in Korea: 9-year changes in nationwide surveys. Cancer Res Treat. 2018; 50:436–444.

29. Arrossi S, Maceira V, Paolino M, Sankaranarayanan R. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey. Vaccine. 2012; 30:2467–74.

30. Mouallif M, Bowyer HL, Festali S, Albert A, Filali-Zegzouti Y, Guenin S, et al. Cervical cancer and HPV: awareness and vaccine acceptability among parents in Morocco. Vaccine. 2014; 32:409–16.